Epidermophyton Floccosum

Generic Name: epidermophyton floccosum

Over-the-Counter (OTC)

Brand Names:

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: EPIDERMOPHYTON FLOCCOSUM (.05 g/mL). Category: BLA.

Overview

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: EPIDERMOPHYTON FLOCCOSUM (.05 g/mL). Category: BLA.

Dosage

Available as solution for intradermal, percutaneous, subcutaneous use.

Related Medications

Durvalumab

durvalumab

Programmed Death Ligand-1 Blocker [EPC]

11 DESCRIPTION Durvalumab is a programmed cell death ligand 1 (PD-L1) blocking antibody. Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that is produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture. IMFINZI (durvalumab) Injection for intravenous use is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow solution, free from visible particles.

Arnica Montana, Rhus Toxicodendron, Ledum Palustre, Calendula Officinalis, Ruta Graveolens

arnica montana, rhus toxicodendron, ledum palustre, calendula officinalis, ruta graveolens

Dosage form: POWDER. Active ingredients: ARNICA MONTANA (30 [hp_X]/12kg); CALENDULA OFFICINALIS FLOWERING TOP (6 [hp_X]/12kg); LEDUM PALUSTRE TWIG (6 [hp_X]/12kg); RUTA GRAVEOLENS FLOWERING TOP (6 [hp_X]/12kg); TOXICODENDRON PUBESCENS LEAF (12 [hp_X]/12kg). Category: DRUG FOR FURTHER PROCESSING.

Ll-37

ll-37

Dosage form: POWDER. Active ingredients: LL-37 (1 g/g). Category: BULK INGREDIENT.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.